Correction: Perivascular diffusion and white matter free water improve identification of cognitive impairment in cerebral small vessel disease - Report - MDSpire
Conexiant’s news site is now MDSpire News. Learn more
Advertisement
Correction: Enhanced Identification of Cognitive Impairment in Cerebral Small Vessel Disease Through Perivascular Diffusion and White Matter Free Water
Clinical Report: Correction on Cognitive Impairment Identification in cSVD
Background
Cerebral small vessel disease is a contributor to cognitive decline and dementia, making accurate identification of cognitive impairment crucial for patient management. Recent advances in neuroimaging techniques, such as perivascular diffusion metrics, have enhanced understanding in this area.
Data Highlights
No numerical or trial data is presented in the correction article.
Key Findings
The correct grant identifier for the study is cPW2025A-16.
The previously assigned identifier 20251021112237092 was incorrectly linked to a different funding source.
The correction emphasizes the importance of accurate funding attribution in research publications.
Clinical Implications
Accurate funding attribution is essential for the integrity of research and its applications in clinical settings. This correction highlights the need for vigilance in reporting research support to maintain transparency in scientific communication.
Conclusion
This correction clarifies the funding details of a significant study on cognitive impairment in cSVD, reinforcing the importance of precise documentation in research.
New findings from CREST-2 are providing important evidence on the role of carotid artery stenting (CAS) in patients with severe asymptomatic carotid stenosis — while underscoring the importance of operator experience, patient selection and procedural technique in achieving favorable outcomes.